Ali Tehrani
Gründer bei Student Biotechnology Network
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Ali Tehrani
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Student Biotechnology Network | Direktor/Vorstandsmitglied | - | - |
Gründer | - | - | |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Direktor/Vorstandsmitglied | - | - |
Creatus Biosciences, Inc.
Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Creatus Biosciences, Inc. operates as an industrial biotechnology company specializing in yeast genetic design and development. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 01.01.2015 | - |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Direktor/Vorstandsmitglied | 03.06.2021 | - |
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Private Equity Investor | 01.03.2022 | - |
Berater | 01.09.2020 | 01.03.2022 | |
Reverb Therapeutics | Direktor/Vorstandsmitglied | 01.07.2023 | - |
Qurcan Therapeutics, Inc. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Karriereverlauf von Ali Tehrani
Ehemalige bekannte Positionen von Ali Tehrani
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 08.09.2003 | 15.01.2022 |
Vorstandsvorsitzender | 08.09.2003 | 15.01.2022 | |
Gründer | 08.09.2003 | 15.01.2022 | |
Präsident | 08.09.2003 | 15.01.2022 | |
ZYMEWORKS INC. | Vorstandsvorsitzender | 01.01.2013 | 15.01.2022 |
Präsident | 01.01.2013 | 15.01.2022 | |
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Ali Tehrani
University of Massachusetts | Graduate Degree |
University of British Columbia | Doctorate Degree |
Statistik
International
Kanada | 12 |
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 8 |
Chief Executive Officer | 2 |
Founder | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ZYMEWORKS INC. | Health Technology |
Private Unternehmen | 10 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
Student Biotechnology Network | |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann. | Commercial Services |
Creatus Biosciences, Inc.
Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Creatus Biosciences, Inc. operates as an industrial biotechnology company specializing in yeast genetic design and development. The company was founded in 2014 and is headquartered in Vancouver, Canada. | Commercial Services |
Premier's Technology Council | Government |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Finance |
Reverb Therapeutics | |
Qurcan Therapeutics, Inc. |
- Börse
- Insiders
- Ali Tehrani
- Erfahrung